Patents by Inventor Francis De Zegher

Francis De Zegher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240000804
    Abstract: The present invention relates to a method and composition for use in treating a condition that benefits from the reduction of hepatic and/or visceral fat, such as polycystic ovary syndrome in adolescent girls or women of childbearing age, involving the use of spironolactone, pioglitazone and metformin.
    Type: Application
    Filed: June 28, 2023
    Publication date: January 4, 2024
    Inventors: Lourdes IBÁÑEZ, Francis DE ZEGHER
  • Publication number: 20190060328
    Abstract: The present invention relates to a method and composition for use in treating a condition that benefits from the reduction of hepatic and/or visceral fat, such as polycystic ovary syndrome in adolescent girls or women of childbearing age, involving the use of spironolactone, pioglitazone and metformin.
    Type: Application
    Filed: October 27, 2016
    Publication date: February 28, 2019
    Applicants: KATHOLIEKE UNIVERSITEIT LEUVEN, HOSPITAL SANT JOAN DE DEU
    Inventors: Lourdes IBAÑEZ, Francis DE ZEGHER
  • Publication number: 20040157809
    Abstract: Novels compositions comprising an endrogen receptor blocker and an insulin sensitizing agent are presented. The use of these compositions for the treatment of persons with an endocrine-metabolic disorder such as polycystic ovary syndrome is disclosed. The novel compositions are able to reduce the levels of triglycerides and male hormones. The novel compositions enables the reduction of preferentially abdominal fat resulting in a change in body composition.
    Type: Application
    Filed: March 30, 2004
    Publication date: August 12, 2004
    Inventors: Francis De Zegher, Lourdes Ibanez
  • Publication number: 20040132650
    Abstract: The present invention presents the use of human Growth Hormone for the manufacture of a medicament for the treatment of abnormal short stature, said short stature being characterized by a Gs protein pathway dysfunction. The invention further present diagnostic methods and diagnostic kits for the determination of Gs pathway dysfunction.
    Type: Application
    Filed: February 6, 2004
    Publication date: July 8, 2004
    Inventor: Francis De Zegher